MANCIA GIUSEPPE

Role
Emeritus Professor  

Publications

  • Cuspidi, C., Facchetti, R., Quarti-Trevano, F., Dell'Oro, R., Faggiano, A., Mancia, G., et al. (2025). New onset left atrial dilatation in the general population: A quarter-century follow-up. EUROPEAN JOURNAL OF INTERNAL MEDICINE [10.1016/j.ejim.2025.05.001]. Detail

  • Mancia, G., Grassi, G., Kjeldsen, S. (2025). When should antihypertensive drug treatment be started? Discrepancies between the 2023 European Society of Hypertension and the 2024 European Society of Cardiology guidelines. ITALIAN JOURNAL OF MEDICINE [10.4081/itjm.2025.1981]. Detail

  • Quarti-Trevano, F., Seravalle, G., Facchetti, R., Tsioufis, K., Dimitriadis, K., Manta, E., et al. (2025). Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity. HYPERTENSION [10.1161/HYPERTENSIONAHA.124.24429]. Detail

  • Cuspidi, C., Facchetti, R., Gherbesi, E., Quarti-Trevano, F., Vanoli, J., Mancia, G., et al. (2025). Increased arterial stiffness and left ventricular remodelling as markers of masked hypertension: findings from the PAMELA population. JOURNAL OF HYPERTENSION, 43(5), 781-789 [10.1097/hjh.0000000000003970]. Detail

  • Mancia, G., Facchetti, R., Quarti-Trevano, F., Grassi, G. (2025). Reproducibility and Treatment Effect on Office and Ambulatory Pressure Relation. HYPERTENSION, 82(1 (January 2025)), 126-135 [10.1161/hypertensionaha.124.23549]. Detail

Research projects

EU-MASCARA-Markers for Sub-Clinical Cardiovascular Risk Assessemnt
Year: 2011
Call: 2011-014 - HEALTH.2011.2.4.2-2
Grantors: UNIONE EUROPEA
Network Enabled Drug Design
Year: 2009
Call: 2009-007 - Bando Fondo per la promozione di accordi istituzionali, Bando accordi istituzionali
Integrating Genomics, clinical Research and care Hypertension
Year: 2005
Call: FP6-LIFESCIHEALTH Life sciences, genomics and biotechnology for health,LSH-2005-2.1.1-2 Hypertension and cardiovascular disease